Fisher Asset Management
MNTA

Fisher Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Fisher Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-53,892
Closed -$1.79M – 899
2020
Q2 		$1.79M Sell
53,892
-12,967
-19% -$413K ﹤0.01% 499
2020
Q1 		$1.82M Sell
66,859
-6,842
-9% -$190K ﹤0.01% 455
2019
Q4 		$1.45M Hold
73,701
– – ﹤0.01% 540
2019
Q3 		$955K Hold
73,701
– – ﹤0.01% 614
2019
Q2 		$918K Hold
73,701
– – ﹤0.01% 607
2019
Q1 		$1.07M Hold
73,701
– – ﹤0.01% 581
2018
Q4 		$814K Buy
73,701
+8,176
+12% +$114K ﹤0.01% 610
2018
Q3 		$1.72M Sell
65,525
-28,407
-30% -$768K ﹤0.01% 536
2018
Q2 		$1.92M Sell
93,932
-27,575
-23% -$592K ﹤0.01% 535
2018
Q1 		$2.21M Sell
121,507
-3,000
-2% -$50K ﹤0.01% 516
2017
Q4 		$1.74M Buy
124,507
+25,984
+26% +$351K ﹤0.01% 535
2017
Q3 		$1.82M Buy
+98,523
New +$1.65M ﹤0.01% 514

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management's MNTA Position: Q3 2020 in Review

Fisher Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 53,892 shares — an estimated $1.79M sold.

Fisher Asset Management first reported a position in MNTA in Q3 2017 and held it in 12 quarters. The position peaked at $2.21M in Q1 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Fisher Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Fisher Asset Management sold 53,892 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.79M.
  • Fisher Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2017 and held it in 12 quarters.
  • Fisher Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $2.21M in Q1 2018.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Fisher Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.